SIRT1: A Potential Therapeutic Target in Autoimmune Diseases
The morbidity and mortality of autoimmune diseases (Ads) have been increasing worldwide, and the identification of novel therapeutic strategies for prevention and treatment is urgently needed. Sirtuin 1 (SIRT1), a member of the class III family of nicotinamide adenine dinucleotide (NAD+)-dependent h...
Guardado en:
Autores principales: | Pan Shen, Xuan Deng, Zhe Chen, Xin Ba, Kai Qin, Ying Huang, Yao Huang, Tingting Li, Jiahui Yan, Shenghao Tu |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c79862036edc469999b0252417bc2fb5 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Pharmacological insights into autophagy modulation in autoimmune diseases
por: Ming-Yue Wu, et al.
Publicado: (2021) -
Características de la hospitalización reumatológica en un hospital de nivel terciario
por: Pacheco R,Daniel, et al.
Publicado: (2001) -
Hidroxicloroquina en el tratamiento de las enfermedades autoinmunes sistémicas
por: Danza,Álvaro, et al.
Publicado: (2016) -
A Case of Rhupus with Rowell Syndrome
por: Almansouri AY, et al.
Publicado: (2020) -
Helicobacter pylori and its association with autoimmune diseases: systemic lupus erythematosus, rheumatoid arthritis and Sjögren syndrome
por: Ivet Etchegaray-Morales, et al.
Publicado: (2021)